Helius Medical Technologies to Present at NobleCon 19th Annual Conference

NEWTOWN, Pa., Nov. 30, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT)

Helius Medical Technologies, a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced that Dane Andreeff, President and Chief Executive Officer, will present at the NobleCon 19th Annual Emerging Growth Equity Conference.

This is a significant opportunity for Helius Medical Technologies to showcase their innovative approach to addressing balance and gait deficits through neuromodulation therapy. The conference provides a platform for industry leaders, investors, and stakeholders to come together and discuss the latest advancements in healthcare technology.

Impact on Individuals:

For individuals dealing with balance and gait deficits, Helius Medical Technologies’ presentation at NobleCon 19th Annual Conference offers hope for a novel therapeutic solution. The company’s focus on neurotechnology and neuromodulation could potentially revolutionize the way these conditions are treated, leading to improved quality of life for patients.

Impact on the World:

Helius Medical Technologies’ innovative approach to addressing neurological disorders could have far-reaching implications for the healthcare industry and beyond. By presenting at events like NobleCon 19th Annual Conference, the company is not only showcasing their own advancements but also contributing to the overall growth and development of neurotechnology as a whole.

Conclusion

Helius Medical Technologies’ participation in the NobleCon 19th Annual Emerging Growth Equity Conference marks a significant milestone in the company’s journey towards revolutionizing the treatment of balance and gait deficits. As they continue to innovate and collaborate with industry partners, the impact of their work is likely to be felt by individuals and the world at large, sparking positive change in the realm of neurotechnology.